Retinal stimulation activates the visual cortex in a topographically correct way. Retina implants are well tolerated in animal experiments. In blind subjects suffering from retinitis pigmentosa in ...
Pioneered by Italian ophthalmologist Benedetto Strampelli in the early 1960s, tooth-in-eye surgery is intended to minimize ...
The biotech company, focused on developing treatments for chronic eye conditions, received Food and Drug Administration (FDA) ...
The investigators conducted a prospective interventional study to determine the therapeutic anatomic and functional effects ...
The implant was also shown to be safe and well ... director of research at Retinal Consultants of Texas and an investigator in the Encelto clinical trials, said in Neurotech’s approval announcement.
Charles C. Wykoff, MD, PhD, Retinal Consultants of Texas, discusses data supporting the FDA approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals), the first and only therapy ...
the Argus II Retinal Prosthesis System, the first and only artificial vision device authorized by the FDA to treat a rare form of blindness called retinitis pigmentosa. Cortigent's platform ...
Retinal implants have gained increasing interest since it was demonstrated in acute trials that completely blind subjects do have light perception upon electrical stimulation of the inner surface ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback